Skip to main content
Top
Published in: Diabetes Therapy 3/2019

Open Access 01-06-2019 | Prediabetes | Original Research

Laboratory Computer-Based Interventions for Better Adherence to Guidelines in the Diagnosis and Monitoring of Type 2 Diabetes

Authors: Maria Salinas, Maite López-Garrigós, Emilio Flores, Javier Lugo, Carlos Leiva-Salinas, the PRIMary Care-LABoratory (PRIMLAB) Working Group

Published in: Diabetes Therapy | Issue 3/2019

Login to get access

Abstract

Introduction

The aim was to present two automated laboratory strategies designed to detect new cases of type 2 diabetes and prediabetes and improve their monitoring.

Methods

To improve diabetes diagnosis, we automatically registered the glycated hemoglobin (HbA1c) levels of every primary care patient between 25 and 46 years old in case of abnormal lipid testing when an HbA1c test had not been requested in the current order or during the previous year and when fasting glucose was > 100 mg/dl. We counted the number of detected cases of diabetes and prediabetes and calculated the cost per identified patient. To improve diabetes monitoring, the levels of HbA1c, total cholesterol, high- and low-density lipoprotein cholesterol and triglycerides and the spot urinary albumin-to-creatinine ratios (ACRs) were automatically registered in patients with diabetes when not ordered according to guidelines. We calculated the total economic costs according to the total number of additional registered tests and reagent cost.

Results

Of 103,425 requests, 224 (0.22%) met the inclusion criteria. Seventeen (7.6%) patients were identified as having new cases of diabetes and 149 (66.5%) of prediabetes, at a cost of €15.2 and €2.3, respectively, per case detected. From 13,874 requests in patients with diabetes, 91 HbA1c and 708 lipid tests and 862 ACRs were automatically registered to comply with guidelines, resulting in expenses of €1948.90.

Conclusions

Making use of laboratory technology, it is possible to detect new cases of type 2 diabetes and prediabetes and to improve disease monitoring.
Literature
9.
go back to reference Hashmi NR, Khan SA. Adherence to diabetes mellitus treatment guidelines from theory to practice: the missing link. J Ayub Med Coll Abbottabad. 2016;28:802–8.PubMed Hashmi NR, Khan SA. Adherence to diabetes mellitus treatment guidelines from theory to practice: the missing link. J Ayub Med Coll Abbottabad. 2016;28:802–8.PubMed
14.
go back to reference Centers for disease control and prevention, National Center for Health statistics, 2013. ICD—ICD-9-CM—International Classification of Diseases, Ninth Revision. Classif Dis Funct Disabil: Clinical Modification; 2013. Centers for disease control and prevention, National Center for Health statistics, 2013. ICD—ICD-9-CM—International Classification of Diseases, Ninth Revision. Classif Dis Funct Disabil: Clinical Modification; 2013.
17.
go back to reference Grimshaw JM, Shirran L, Thomas R, et al (2001) Changing provider behavior: an overview of systematic reviews of interventions. Med Care 39:II2-45CrossRef Grimshaw JM, Shirran L, Thomas R, et al (2001) Changing provider behavior: an overview of systematic reviews of interventions. Med Care 39:II2-45CrossRef
20.
go back to reference Salinas M, López-Garrigós M, Pomares F, et al. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT). Bone. 2013;56:73–6.CrossRef Salinas M, López-Garrigós M, Pomares F, et al. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT). Bone. 2013;56:73–6.CrossRef
23.
go back to reference UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
26.
go back to reference Gavin JR, Freeman JS, Shubrook JH, Lavernia F (2011) Type 2 diabetes mellitus: practical approaches for primary care physicians. J Am Osteopath Assoc 111:S3–12 (quiz S13)PubMed Gavin JR, Freeman JS, Shubrook JH, Lavernia F (2011) Type 2 diabetes mellitus: practical approaches for primary care physicians. J Am Osteopath Assoc 111:S3–12 (quiz S13)PubMed
29.
go back to reference WHO. Global report on diabetes. Geneva: WHO; 2017. WHO. Global report on diabetes. Geneva: WHO; 2017.
Metadata
Title
Laboratory Computer-Based Interventions for Better Adherence to Guidelines in the Diagnosis and Monitoring of Type 2 Diabetes
Authors
Maria Salinas
Maite López-Garrigós
Emilio Flores
Javier Lugo
Carlos Leiva-Salinas
the PRIMary Care-LABoratory (PRIMLAB) Working Group
Publication date
01-06-2019
Publisher
Springer Healthcare
Published in
Diabetes Therapy / Issue 3/2019
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-019-0600-z

Other articles of this Issue 3/2019

Diabetes Therapy 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.